Difference between revisions of "Fluorouracil (5-FU)"
m (→References) |
m (→References) |
||
Line 190: | Line 190: | ||
[[Category:Drugs FDA approved in 1962]] | [[Category:Drugs FDA approved in 1962]] | ||
+ | [[Category:WHO Essential Cancer Medicine]] |
Revision as of 18:47, 5 June 2016
General information
Class/mechanism: Pyrimidine analog, antimetabolite, inhibitor of thymidylate synthase. Metabolized to 5-fluoro-2'-deoxyuridine monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP). FdUMP inhibits DNA synthesis by binding to thymidylate synthase and inhibiting production of thymidylate; FUTP interferes with RNA processing when it is mistakenly incorporated in place of uridine triphosphate (UTP).[1][2] [3].
Route: IV
Extravasation: irritant
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
- Anal cancer
- Bladder cancer
- Breast cancer
- Cervical cancer
- Colon cancer
- Esophageal cancer
- Gastric cancer
- Head and neck cancer
- Hepatobiliary cancer
- Neuroendocrine tumors
- Pancreatic cancer
- Penile cancer
- Prostate cancer
- Rectal cancer
- Unknown primary
Patient drug information
- Fluorouracil (5-FU) patient drug information (Chemocare)[4]
- Fluorouracil (5-FU) patient drug information (UpToDate)[5]
History of changes in FDA indication
- 4/25/1962: Initial FDA approval
Also known as
Synonyms | |||||||
---|---|---|---|---|---|---|---|
5 Fluorouracil | 5 FU | 5 FU Kyowa Hakko | 5 FU Meiji | 5 FU Orca | 5-fluoracilo | 5-fluorouracilo | 5-fluorouracyl-knoll |
5-FU Kyowa | 5-FU Medac | Accusite | Actino Hermal | Adrucil | Arumel | Benton | Biofur |
Carac | Carebin | Carzonal | Cinco-FU | Cinkef-U | Curacil | Effcil | Efudex |
Efurix | Ezadex | Fauldfluor | Fivocil | Fivoflu | Flacule | Flonida | Florac |
Flourouracil | Fluhomer | Fluolex | Fluor-Uracil | Fluoro-Uracile ICN | Fluoro-Uracil ICN | Fluoroplex | Fluorouracil |
Fluorouracil-GRY | Fluorouracil 5 FU | Fluorouracil Abic | Fluorouracil Bigmar | Fluorouracil CO | Fluorouracil DBL | Fluorouracile | Fluorouracile Dakota |
Fluorouracil Faulding | Fluorouracil Mayne | Fluorouracil Mayne Pharma ( BEN ) | Fluorouracilo | Fluorouracilo Filaxis | Fluorouracilo Martian | Fluorouracilo Rontag | Fluorouracil Pliva |
Fluorouracil Roche | Fluorouracil Sanofi-Synthelabo | Fluorouracil Sodium | Fluorouracil Till | Fluorourcil | Fluoruracilo | Fluoxan | Flurablastin |
Flurac | Fluracedyl | Fluracil | Fluroblastin | Fluroblastine | Ftoruracil | Ftouracil | FU |
FU Kyorin | FU MI TE | FU Schering | Haemato-FU | Ifacil | Kang Ning | Kecimeton Tatumi | Killit |
LA FU | Lunachol DS Sawai | Lunachol Yoshitomi | Lunapon | Natira U | Neofluor | O Fluor | Oncofu |
Onkofluor | Pentafu | Pharmauracil | Phthoruracil | Phtoruracil | Ribofluor | Rotianin | Sanc F D |
Satelol | Seco Uracil | Tecflu | Timadin | Timadin Dry | Trav Fluorouracil | Triosules | Uflahex |
Ulosagen | Ulup Maruko | Ulup Mitsubishi | Uraciflor | Utoral | Vaflu | Vafu | Zhongren FU AN |
References
- Drug index
- Chemotherapy
- Intravenous chemotherapy
- Irritant chemotherapy
- Antimetabolites
- Pyrimidine analogues
- Anal cancer medications
- Bladder cancer medications
- Breast cancer medications
- Cancer of unknown primary medications
- Cervical cancer medications
- Colon cancer medications
- Esophageal cancer medications
- Gastric cancer medications
- Head and neck cancer medications
- Hepatobiliary cancer medications
- Neuroendocrine tumor medications
- Pancreatic cancer medications
- Penile cancer medications
- Prostate cancer medications
- Rectal cancer medications
- Drugs FDA approved in 1962
- WHO Essential Cancer Medicine